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Abstract
A total of 141 Streptococcus pneumoniae isolates from patients with community-acquired pneumonia were collected from May 2003
through October 2004. The strains were tested for antimicrobial agent susceptibility, serotype and genotype by multilocus sequence
typing (MLST) and the presence of the pilus rlrA islet. MLST analysis identiﬁed 49 sequence types (STs), of which 19 were novel.
eBURST analysis using the MLST database (3773 STs) grouped the isolates into 27 clonal complexes and three singletons. A total of 92
(65.2%) isolates were related to ten of the 43 international Pneumococcal Molecular Epidemiology Network (PMEN) clones; major
clones found were multidrug-resistant Netherlands3-31 [clonal complex (CC) 180], Taiwan19F-14 (CC271), Taiwan23F-15 (CC242), and
Colombia23F-26 (CC138) (the latter new to Asia). We adopted univariate and multiple logistic regression models to identify factors
associated with PMEN CCs. Multivariate analysis showed that multidrug resistance (OR 6.3; 95% CI 2.0–22.9), carriage serogroups (OR
7.2; 95% CI 2.5–23.7), prevalence of rlrA (OR 12.6; 95% CI 3.6–59.7) and central nervous system-related disorders (OR 7.7; 95% CI
1.8–48.4) were independently associated with PMEN CCs. Our data indicate that multidrug-resistant PMEN clones are highly prevalent,
contributing to the high frequency of resistance to antimicrobial agents in Japan, and suggest that certain predisposing factors in patients
contribute to the high frequency of these clones.
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Introduction
Several clinical and epidemiological studies of Streptococcus
pneumoniae have revealed that a small number of dominant
resistant clones is responsible for the spread of S. pneumoniae
resistance to different classes of antimicrobials [1]. Although
increased antibiotic use has been the most important selec-
tive force driving the appearance and circulation of resistant
strains [2], other, as yet unidentiﬁed, mechanisms of dissemi-
nation and successful establishment of such clones are likely.
Multilocus sequencing typing (MLST) is a nucleotide
sequence-based approach for characterizing isolates of bacteria
and other organisms via the internet (http://www.mlst.net/),
having the advantage over pulsed-ﬁeld gel electrophoresis
of ease of manipulation and unambiguous and convenient
comparison [3]. The Pneumococcal Molecular Epidemiology
Network (PMEN) includes 26 multidrug-resistant and 17 sus-
ceptible S. pneumoniae clones found worldwide using MLST
(http://www.sph.emory.edu/PMEN/) [4]. In Asian countries,
Spain23F-1, Spain6B-2, Taiwan19F-14, Taiwan23F-15 and
Netherlands3-31 have been spreading, which could be a
major reason for the rapid increases in penicillin- and macro-
lide-resistant S. pneumoniae strains [5–8].
Because the ecological niche of S. pneumoniae is the human
nasopharynx, horizontal transfer of antimicrobial resistance
genes occurs easily via commensal organisms that reside in the
nasopharynx [9]. Various pneumococcal virulence factors have
a role to play in bacterial colonization and disease [10,11].
Although at least 90 different capsular serotypes have
been described, their carriage potentials differ [12]. Bruegg-
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eman et al. have performed a meta-analysis to calculate the
ORs for different serogroups/serotypes causing invasive
diseases. Using serotype 14 as the reference for serogroups/
serotypes, it was concluded that 1, 5 and 7 cause more
invasive disease, whereas 18, 9, 8, 33, 38, 19, 6, 23, 3 and 15
are responsible for carriage, irrespective of any temporal
change or major geographical differences [13]. Recent studies
have revealed that pneumococcal pili encoded by the rlrA
islet also enhance adherence to lung epithelial cells [14] and
that the presence of the rlrA gene was correlated more with
MLST genotypes than with serotypes; the rlrA gene was also
found to be carried in several PMEN clones [15–17].
Furthermore, different host factors, such as male gender,
smoking, recent antibiotic use, attendance at day care cen-
tres, as well as various underlying diseases, all predispose to
pneumococcal colonization [10,18,19].
In the present study, we performed MLST for S. pneumo-
niae isolates collected from patients with community-
acquired pneumonia (CAP) in Japan in order to investigate
clonal spread of the bacteria, especially the PMEN clones.
We then employed univariate and multiple logistic regression
models to identify microbiological and clinical risk factors
associated with the prevalent PMEN clones compared with
the non-PMEN isolates.
Material and Methods
Study design, bacterial strains and clinical data
total of 141 pneumococcal isolates that had been prospectively
collected from patients >15 years old diagnosed with CAP
between May 2003 and October 2004 in Japan have been previ-
ously described [20]. In brief, the sources were sputum
(n = 132), blood (n = 6), transtracheal aspiration (n = 2) and
bronchoalveolar lavage (n = 1). On the basis of sociodemo-
graphic and clinical data, we calculated the Charlson comorbidi-
ty index [21] and the Pneumonia Severity Index [22]. The study
was approved by the Ethics Committees of each hospital.
MLST
The bacterial strains were analysed by MLST, as described elsewhere
[3]. In order to determine nucleotide sequences of new alleles, we
used three new primers: xpt2-up, TCGCTCGTAATAGTTTTATC,
ddl2-up, AAATGCCTTACGTTGGTTGC, and ddl2-dn, GCGCT
TGTCAAAACTTTCCT. The sequence types (STs) were
obtained by reference to the MLST database (http://
www.mlst.net/). New alleles and new STs were submitted to
the curator of the database and were assigned designations.
ST180, ST2808 and ST2809 isolates in the present study have
already been described in our previous report [6].
eBURST analysis for clonal complexes
To visualize the genetic relationships among the different
strains, a dendrogram was generated from the distance matrix
between STs by using the unweighted pair group method with
arithmetic averages on the PubMLST website (http://
pubmlst.org/). eBURST was carried out to estimate the
relationship of isolates with software (http://spneumoniae.
mlst.net/eburst/). Clonal complexes (CCs) consisted of
eBURST sets in which all STs share six of seven identical alleles
with at least one other ST within the group [single-locus vari-
ants (SLV)]. We ran eBURST with default settings associating
each ST with a CC on the entire MLST database (3773STs)
and STs newly assigned within our dataset. In this study, we
named CCs according to an ST number of the eBURST
predicted founder, deﬁned as being the ST with the greatest
number of SLVs, a smaller number of STs in a group consisting
of two different STs or a singleton itself.
Antimicrobial susceptibility and serotyping
We have already reported the antimicrobial agent suscepti-
bilities and serotypes of 141 isolates [20,23]. In brief,
non-susceptibility to penicillin, erythromycin, ceftriaxone,
clindamycin, minocycline and trimethoprim-sulfamethoxazole
was recorded in 64 (45.4%), 118 (83.7%), ﬁve (3.5%), 77
(54.6%), 116 (82.3%) and 41 isolates (29.1%), respectively.
Multidrug resistance includes three or more antimicrobial
non-susceptibilities. According to a meta-analysis [13], we
divided the serotypes into three different groups with
different invasive disease potential in our collection. These
were high (invasive), serotype 7; medium, 4, 9N, 9V and 14;
and low (carriage), 3, 6A, 6B, 15, 19A, 19F, 23A and 23F.
Detection of the rlrA islet
The genomic location of the rlrA islet was determined by simul-
taneously assessing ﬁve PCR ampliﬁcations, as previously
reported [15,16]. If the rlrA islet or parts of it were absent, the
PCR product using these primers would be similar in length to
DNA as mainly type A (1310 bp), type B (1912 bp) or type C
(2616 bp).
Statistical analysis
Statistical analysis was performed using JMP version 6.03 (SAS
Campus Drive, Cary, NC, USA). Related factors and outcomes
for PMEN clonal genotypes were identiﬁed by comparison
with non-PMEN genotypes using univariate analysis.
Associations between categorical variables were tested by
the Pearson v2 or Fisher’s exact test, when appropriate.
Means of continuous variables were compared by Student’s
t-test or Mann–Whitney U-test, as appropriate. ORs and the
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respective 95% CIs were computed as an estimate of the rel-
ative risk. Variables were selected for further analysis if their
probability values were <0.05 by univariate analysis. In order
to avoid problems of multi-colinearity, correlations among
predictor variables were analysed ﬁrst and then multiple
logistic regression analysis was performed. All tests were
two-tailed and probability values of £0.05 were considered
statistically signiﬁcant.
Results
MLST and the BURST analysis
Among 141 isolates, 49 STs were found in the MLST analysis
and a dendrogram was constructed (Fig. 1). We identiﬁed
nine new allele sequences (aroE112, gdh171, gki175, gki192,
xpt233, xpt234, ddl271, ddl279 and ddl281) and 19 new STs,
of which eight contained these alleles (STs 2925, 2983, 3110,
3112, 3116, 3193, 3194 and 3542) and 11 contained new
allelic proﬁles of the known alleles (STs 2922, 2923, 2924,
3109, 3111, 3113, 3114, 3115, 3117, 3118 and 3543). The
frequencies of the STs with multiple isolates did not differ in
any of the participating hospitals. eBURST analysis revealed
the presence of 27 CCs and three singletons, encompassing
10 PMEN CCs (92 isolates, 65.2%, Table 1).
Serotypes
Almost every ST was well correlated with one serotype
except for ST236, ST242 and ST2924, indicating serotype
switching. On the other hand, in numerous serotypes, iso-
lates within the same serotype contained multiple STs
(Fig. 1). Carriage serotypes were signiﬁcantly associated with
PMEN CCs (Table 2).
Antimicrobial susceptibility
Antimicrobial agent susceptibilities for each CC are shown
in Table 1. PMEN clones among penicillin non-susceptible,
erythromycin non-susceptible and multidrug-resistant isolates
were found in 49 (76.6%), 87 (73.7%) and 84 (77.8%)
isolates, respectively. Resistance to various antimicrobials
FIG. 1. Genetic relationships, multilocus
sequence typing proﬁles and serotypes
among the 49 sequence types (STs) of
141 Streptococcus pneumoniae isolates
from community-acquired pneumonia
patients, Japan, 2003–2004. The dendro-
gram was generated from a distance
matrix between STs by using the un-
weighted pair group method with arith-
metic averages. aNew STs and alleles in
bold. bIn the order aroE-gdh-gki-recP-spi-
xpt-ddl. cCC, clonal complex; S, single-
ton. dSLV, single locus variants; DLV,
double locus variants. eNT, non-type-
able. fNumber of isolates.
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and combinations of erythromycin, clindamycin and mino-
cycline was signiﬁcantly associated with PMEN clones
(Table 2). Strains with resistance to combinations of erythro-
mycin, clindamycin and minocycline were found in CC180
(33 isolates), CC90 (1), CC199 (1), CC271 (1), CC280 (1),
CC433 (1), CC1452 (1) and CC2924 (1). Most of the multi-
drug-resistant isolates, including those with erythromycin,
clindamycin and minocycline resistance, belonged to carriage
serotypes (90/108 isolates, 83.3%). Among these carriage
serotypes, multidrug resistance was found more frequently in
PMEN CCs (75/79 isolates, 94.9%) than in non-PMEN CCs
(15/20 isolates, 75%, p 0.02).
Prevalence of rlrA
A total of 43 (30.5%) isolates were positive for the rlrA gene,
especially in PMEN CCs (Table 2). PCR analysis showed the
rlrA islet consistently inserted into the same genomic region.
Among isolates without rlrA, types A, B and C comprised 92,
one and ﬁve isolates, respectively. The frequency of rlrA was
correlated more often with MLST genotypes than with sero-
types. Serotype 4 (three isolates) and 7 (one isolate) had rlrA
in all serospeciﬁc isolates, whereas serotypes 6B, 11A, 14,
19A, 19F, 23F, 35B and non-typeable had rlrA only in some
of the serospeciﬁc isolates. Among carriage serotypes, the
rlrA gene was more common in PMEN CCs (39.2%) than in
non-PMEN CCs (5.0%, p 0.003).
Factors associated with the PMEN clones
Factors associated with PMEN CCs compared with
non-PMEN CCs upon univariate analysis are shown in
Table 2. Multiple logistic regression analysis revealed that
multidrug resistance including erythromycin, clindamycin and
minocycline resistance (OR 6.3, 95% CI 2.0–22.9, p 0.0026),
carriage serotypes (OR 7.2, 95% CI 2.5–23.7, p 0.0005), the
presence of rlrA (OR 12.6, 95% CI 3.6–59.7, p 0.0003) and
central nervous system (CNS) disorders (OR 7.7, 95% CI
1.8–48.4, p 0.014) were all signiﬁcantly associated with the
PMEN CCs.
Discussion
Several molecular epidemiological studies of S. pneumoniae
have shown that the frequencies of antimicrobial-resistant
TABLE 1. Non-susceptibility and presence of rlrA in each clonal complex among Streptococcus pneumoniae
Clonal complex No. of isolates
Non-susceptible rate (%)
Prevalence of rlrA (%)PEN ERY CRO CLI MIN SXT MDRa
PMEN clonal complex
180 Netherlands3-180 37 95 95 89
271 Taiwan19F-236 22 91 100 5 32 100 73 95 91
242 Taiwan23F-242 10 100 100 70 100 30 100 100
138 Colombia23F-338 8 100 100 13 100 100
15 England14-9 4 75 100 25 50 75 25 75
558 Utah35B-377 4 100 50 25 50 25 50 100
90 Spain6B-90 3 67 100 67 100 67 67 100
156 Spain9V-156 2 100 100 50 50 100 100 100 100
66 Tennessee14-67 1
199 Netherlands15B-199 1 100 100 100
Non-PMEN clonal complex
280 6 83 50 50
433 5 20 20 20
3113 5 60 80 20 80 100 80 80
2331 4 25 25 50
247 3 33 33 100
490 3 100 67 33 100 100 100
554 3 100 100 33 100 100 100
2924 3 33 100 100 100 67 67
3110 3 67 67 67 100 67
99 2 50
1012 2 100 100
1452 2 100 50 100 50 50
447 1
1426 1 100 100 100 100 100 100
1437 1 100 100 100 100 100 100
2755 1 100 100 100 100
2809 1 100 100 100 100
3115 1 100 100 100 100
3116 1
3194 1
Data are presented as numbers or % of isolates. Clonal complex of each singleton is named in accordance with its sequence type number.
PMEN, Pneumococcal Molecular Epidemiology Network; PEN, penicillin; ERY, erythromycin; CRO, ceftriaxone; CLI, clindamycin; MIN, minocycline; SXT, trimethoprim-sulfa-
methoxazole.
aMultidrug resistance, including three or more antimicrobial non-susceptibilities except for combined ERY–CLI–MIN resistance.
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PMEN clones 1–26 were 55.5–71.8%, 51.2% and 69.2%
among penicillin non-susceptible, erythromycin- and multi-
drug-resistant isolates, respectively [24–27]. Also in the pres-
ent study, antimicrobial-resistant PMEN clones 1–26,
excluding CC180 and CC199, were included in 76.6% of
penicillin non-susceptible, 43.2% of erythromycin- and 38.3%
of multidrug-resistant isolates.
Furthermore, the frequency of PMEN CCs was high
(65.2%) overall in these S. pneumoniae isolates, which con-
tributes to the high frequency of antimicrobial-resistant
S. pneumoniae strains in the community in Japan.
CC180 was ﬁrst described as a penicillin- and erythromy-
cin-susceptible invasive isolate (http://www.sph.emory.edu/
PMEN/).We previously reported that multidrug-resistant
Netherlands3-31/ST180 (CC180) was the most prevalent
clone in this cohort study [6]. This is a variant of CC180
clone with erythromycin–clindamycin–minocycline resistance
that is currently spreading in Japan.
Previous molecular epidemiological studies of S. pneumoniae
clones have shown that penicillin- and erythromycin-resistant
Taiwan19F-14/ST236 (CC271) and Taiwan23F-15/ ST242
(CC242) have been prevalent in Asia for some time [5,7,8].
These multidrug-resistant clones were also the second and
the third most common isolates in the present study.
Colombia23F-26/ST338 (CC138) was originally reported as
an isolate with susceptibility to penicillin (MIC, 0.064 mg/L)
(http://www.sph.emory.edu/PMEN/); in contrast, the CC138
isolates in the present study have acquired multidrug resis-
tance (Table 1) and the serotype of all the CC138 isolates
switched to 23A (Fig. 1). Recently, a new association of sero-
type 23A isolates with Colombia23F-26/ST338 has emerged
in the USA after introducing the seven-valent pneumococcal
conjugate vaccine [28]. Although Colombia23F-26/ST338
has not been reported in Asian countries so far, and the
seven-valent pneumococcal conjugate vaccine has not yet
been introduced in Japan, multidrug-resistant serotype 23A/
TABLE 2. Clinical and microbial characteristics and factors associated with Pneumococcal Molecular Epidemiology Network
(PMEN) clones
Characteristics All cases N = 141
Infection due to
OR 95% CI p
PMEN Non-PMEN
n = 92 n = 49
Age (years) 66.7 ± 15.1 65.7 ± 15.2 68.6 ± 14.9 0.28
Male gender 67.4 66.3 69.4 0.87 0.4–1.8 0.71
Mortality 5.8 5.6 6.2 0.90 0.2–3.9 1.00
Charlson index (point) 1.44 ± 1.6 1.4 ± 1.2 1.4 ± 2.1 0.99
PSIa score (point) 84.3 ± 36.3 84.0 ± 33.6 85.0 ± 41.4 0.88
Asthma 13.5 14.1 12.2 1.18 0.4–3.3 0.75
COPDb 19.9 20.7 18.4 1.16 0.5–2.8 0.75
Chronic heart disease 14.2 15.2 12.2 1.29 0.5–3.6 0.63
CNSc disorders 15.6 20.7 6.1 3.99 1.1–14.2 0.03
Previous antibiotic use 10.6 13.0 6.1 2.30 0.6–8.6 0.26
Previous macrolide use 5.0 7.6 0.0 0.10
Smoking status
Current 24.4 23.5 26.2 0.87 0.4–2.0 0.74
Former 35.4 37.7 31.0 1.35 0.6–3.0 0.46
Sputum collection 93.6 93.5 93.9 0.93 0.2–3.9 1.00
Serogroup
Invasived 0.7 1.1 0.0 1.00
Mediume 11.4 6.5 20.4 0.27 0.1–0.8 0.01
Carriagef 70.2 85.9 40.8 8.81 3.9–20.0 <0.001
Presence of rlrA 30.5 42.4 8.2 8.28 2.7–24.9 <0.001
Antimicrobial non-susceptibility
Penicillin 45.4 53.3 30.6 2.58 1.2–5.4 0.01
Erythromycin 83.7 94.6 63.3 10.10 3.5–29.5 <0.001
Ceftriaxone 3.6 3.3 4.1 0.79 0.1–4.9 1.00
Clindamycin 54.6 62.0 40.8 2.36 1.2–4.8 0.02
Minocycline 82.3 91.3 65.3 5.58 2.2–14.2 <0.001
SXTg 29.1 27.2 32.7 0.77 0.4–1.6 0.50
ERY-CLI-MINh 28.4 39.1 8.2 7.23 2.4–21.8 <0.001
MDRi 48.2 52.2 40.8 1.58 0.8–3.2 0.20
Multidrug resistance 76.6 91.3 49.0 10.94 4.4–27.3 <0.001
Data are presented as mean ± SD or % of patients. Statistical analyses were performed using the non-PMEN CCs group as a comparison.
aPneumonia severity index.
bChronic obstructive pulmonary disease.
cCentral nervous system.
dSerogroup 7.
eSerogroups 4, 9 and 14.
fSerogroups 3, 6, 15, 19, 23.
gTrimethoprim-sulfamethoxazole.
hCombined erythromycin–clindamycin–minocycline resistance.
iMultidrug resistance except for combined ERY–CLI–MIN resistance.
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CC138 isolates were the fourth most prevalent in the pres-
ent study. CC138 needs to be monitored closely, as it seems
to be a very biologically successful clone in Japan as well as
in the USA.
Other PMEN clones in the present study have been iso-
lated predominantly in European countries and the USA
[24,26,29]. Except for CC66, these CCs also developed mul-
tidrug-resistant isolates (Table 1). As a result, almost all
PMEN CCs in the present study were resistant to multiple
antimicrobial agents (Table 2).
In the present study, multidrug-resistant isolates were
observed more frequently in most of the carriage serotypes
(90.9%) than in medium carriage and invasive serotypes
(52.9%). Among ten PMEN CCs, carriage serotypes were
observed in six, three of which have already been reported to
be multidrug-resistant clones (CC90, CC271 and CC242) and
the remaining three CCs (CC180, CC138 and CC199) devel-
oped multidrug-resistant isolates. Four major PMEN CCs
(CC180, CC271, CC242 and CC138) had carriage sero-
types and multidrug resistance (Table 1).
As a result, the rates of carriage serotypes as well as
multidrug resistance in the PMEN CCs were higher than in
non-PMEN CCs (Table 2). Thus, PMEN clones with carriage
serotypes probably acquire multidrug resistance easily in the
community.
Our study has also shown that the presence of rlrA corre-
lated to particular CCs, especially in PMEN clones (Table 1).
Among carriage serotypes, rlrA was much more frequent in
PMEN CCs (39.2%) than in non-PMEN CCs (5.0%), suggest-
ing that rlrA confers an advantage for dissemination even
among carriage-potential and antimicrobial-resistant isolates.
We expected that the CAP patients infected with PMEN
clones were likely to have possessed risk factors for coloni-
zation and antimicrobial resistance, such as smoking, previous
antimicrobial use, and reported comorbidities. However,
these patients manifested only CNS disorders, which are
likely to be associated with aspiration pneumonia. Even a
small amount of nasal carriage of bacteria leads to aspiration
pneumonia in a murine stroke model [30]. We speculate that
patients with CNS disorders may not be especially frequently
colonized by PMEN clones, but may more easily develop
aspiration pneumonia after colonization.
This study has some limitations. First, our sample size was
not sufﬁciently large to identify various risk factors. Second,
some non-PMEN CCs may be included in the PMEN CCs in
the future. For example, CC433/serotype 22F has been
reported in meningitis patients from Poland [31], invasive
isolates in the USA [29] and clinical isolates in Scotland [32].
Even when we included CC433 in the PMEN CCs, the
microbiological and host factors associated with clonal
spread remained signiﬁcant in a multiple logistic regression
model (data not shown). Third, we could not clarify why
CC180 and CC138 without rlrA had any other selective
advantages than carriage serotypes and multidrug resistance
in the present study.
In conclusion, among S. pneumoniae isolates from adult
patients with CAP in Japan, multidrug-resistant PMEN clones
were highly prevalent, contributing to the high frequency of
antimicrobial resistance in Japan. Carriage potential serotypes,
the presence of rlrA, multidrug resistance and patients with
CNS disorders were signiﬁcantly associated with CAP patients
infected with PMEN CCs. Continuous surveillance of pheno-
typic data, genotyping and clinical manifestations and investiga-
tions of pneumococcal virulence factors for prevalent clones
will be necessary to understand the spread of successful clones.
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